Background: TRACK-HD is a multinational prospective observational study of Huntington's disease (HD) that examines clinical and biological findings of disease progression in individuals with premanifest HD (preHD) and early-stage HD. We aimed to describe phenotypic changes in these participants over 36 months and identify baseline predictors of progression
Background: The lack of reliable biomarkers to track disease progression is a major problem in clini...
Background and ObjectivesLongitudinal measurements of brain atrophy using structural MRI (sMRI) can ...
TRACK-HD is a multicentre longitudinal observational study investigating the use of clinical assessm...
Background TRACK-HD is a prospective observational study of Huntington's disease (HD) that examines ...
BACKGROUND: TRACK-HD is a prospective observational study of Huntington's disease (HD) that examines...
BACKGROUND: TRACK-HD is a prospective observational biomarker study in premanifest and early Hunting...
International audienceVariability in neurodegenerative disease progression poses great challenges fo...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
BACKGROUND: Huntington's disease (HD) is an autosomal dominant, fully penetrant, neurodegenerative d...
BackgroundAlthough the association between cytosine-adenine-guanine (CAG) repeat length and age at o...
In Huntington's disease (HD), accurate estimates of expected future motor impairments are key for cl...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
The Unified Huntington's Disease Rating Scale is used to characterize motor impairments and establis...
The Unified Huntington's Disease Rating Scale is used to characterize motor impairments and establis...
Background: The lack of reliable biomarkers to track disease progression is a major problem in clini...
Background and ObjectivesLongitudinal measurements of brain atrophy using structural MRI (sMRI) can ...
TRACK-HD is a multicentre longitudinal observational study investigating the use of clinical assessm...
Background TRACK-HD is a prospective observational study of Huntington's disease (HD) that examines ...
BACKGROUND: TRACK-HD is a prospective observational study of Huntington's disease (HD) that examines...
BACKGROUND: TRACK-HD is a prospective observational biomarker study in premanifest and early Hunting...
International audienceVariability in neurodegenerative disease progression poses great challenges fo...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
BACKGROUND: Huntington's disease (HD) is an autosomal dominant, fully penetrant, neurodegenerative d...
BackgroundAlthough the association between cytosine-adenine-guanine (CAG) repeat length and age at o...
In Huntington's disease (HD), accurate estimates of expected future motor impairments are key for cl...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
The Unified Huntington's Disease Rating Scale is used to characterize motor impairments and establis...
The Unified Huntington's Disease Rating Scale is used to characterize motor impairments and establis...
Background: The lack of reliable biomarkers to track disease progression is a major problem in clini...
Background and ObjectivesLongitudinal measurements of brain atrophy using structural MRI (sMRI) can ...
TRACK-HD is a multicentre longitudinal observational study investigating the use of clinical assessm...